Entegris Extends Life Sciences Production Facilities

Semiconductor supplier Entegris Inc ENTG has expanded its Life Sciences manufacturing facilities in Billerica, MA; Bloomington, MN, and Logan, UT.
The expansions are part of Entegris' Capex plan to invest $30 million in life sciences volume and abilities in 2021, apart from the $10 million investment in 2020.
The facilities will develop and manufacture bioprocessing assemblies like Aramus critical fluid handling product lines currently used to produce and deliver vaccines globally.
Entegris plans to hire around 200 additional employees with engineering and production experience throughout 2021.
Entegris also has started developing its Life Sciences Technology Center in Billerica, MA.
The facility will provide application testing, process development, and solution demonstration services for bioprocess technologies, including freeze, thaw, and filtration applications.
Price action: ENTG shares traded lower by 1.02% at $115.04 on the last check Monday.